Greenlane Renewables stock (CA39340L1085): Biogas specialist posts modest revenue growth and improving margins in 2023

Greenlane Renewables reported modest revenue growth and improving margins in 2023, with Q4 revenue of about $17.3 million and a shift toward positive operating cash flow.

Greenlane Renewables stock has drawn attention from investors focused on renewable natural gas and biogas infrastructure after the company reported modest revenue growth and improving margins in 2023. In the fourth quarter of 2023, Greenlane generated revenue of about $17.3 million, up from roughly $17 million in the same quarter of 2022, according to a transcript of the Q4 2023 earnings call compiled by Alpha Spread Alpha Spread as of 2024. The company highlighted progress on project execution and a continued focus on its biogas upgrading systems business.

As of: 10.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Greenlane Renewables Inc.
• Sector/industry: Energy / Renewable energy equipment
• Headquarters/country: Canada
• Core markets: North America, Europe
• Key revenue drivers: Biogas upgrading projects and aftercare services
• Home exchange/listing venue: Toronto Stock Exchange (TSX: GRN)
• Trading currency: Canadian dollars

Greenlane Renewables: core business model

Greenlane Renewables designs, develops, sells, and services biogas upgrading systems that remove impurities from raw biogas and convert it into clean, renewable natural gas. The company’s systems are used at landfills, wastewater treatment plants, dairy farms, and food?waste facilities, producing gas that can be injected into the natural gas grid or used as vehicle fuel. Greenlane positions itself as a technology provider that helps customers monetize organic waste while reducing greenhouse?gas emissions.

The company operates with two main revenue streams: upgrader projects and aftercare services. Upgrader projects, which involve the design, supply, and commissioning of biogas upgrading systems, represent the largest share of revenue. Aftercare services include maintenance, spare parts, and technical support, providing a recurring revenue component. Greenlane’s business model is therefore project?driven but with a growing service element that can smooth cash flows over time.

Main revenue and product drivers for Greenlane Renewables

Greenlane’s revenue is driven by the number and size of biogas upgrading projects it wins, particularly in North America, where it generates the majority of its sales. The company offers several technologies, including water wash, pressure swing adsorption, and membrane separation, allowing it to tailor systems to different feedstocks and customer requirements. This technology portfolio supports Greenlane’s ability to compete in diverse regulatory and market environments.

Recent financial data indicate that Greenlane has been able to maintain revenue in the low?40?million?dollar range over the last 12 months, with trailing?12?month revenue of about CAD 41–44 million and modest losses, according to statistics compiled by StockAnalysis and Simply Wall St StockAnalysis as of 2024Simply Wall St as of 2024. Gross margins have been in the low?40?percent range, while net profit margins remain slightly negative, reflecting ongoing investments and project?related costs.

Why Greenlane Renewables matters for US investors

For US investors, Greenlane Renewables offers exposure to the renewable natural gas and biogas sector, which is gaining policy and regulatory support in North America. The company’s systems are deployed at sites that generate methane from organic waste, a potent greenhouse gas, and convert it into a usable fuel, aligning with decarbonization goals. As US states and utilities look to expand renewable gas capacity, demand for upgrading technologies could grow, potentially benefiting Greenlane’s project pipeline.

Greenlane’s listing on the Toronto Stock Exchange provides US?based investors with access to a small?cap renewable?energy name without direct US listing. The stock’s relatively small market capitalization, in the low?30?million?dollar range, means it can be more volatile than larger peers but may also offer higher sensitivity to project wins and policy developments. US investors interested in the biogas value chain may view Greenlane as a niche play on infrastructure rather than a pure?play producer.

Conclusion

Greenlane Renewables has shown modest revenue growth and improving operational metrics in 2023, with Q4 revenue around $17.3 million and a move toward positive operating cash flow. The company’s focus on biogas upgrading systems positions it at the intersection of waste management and renewable energy, a segment that may benefit from long?term decarbonization trends in North America and Europe. However, Greenlane remains a small?cap stock with narrow margins and project?dependent earnings, which can lead to volatility and execution risk.

For US investors, Greenlane offers a niche exposure to renewable natural gas infrastructure rather than direct commodity exposure. The stock’s appeal will depend on the company’s ability to secure new projects, maintain healthy margins, and convert its net cash position into sustainable growth. As with any small?cap energy name, investors should weigh the potential upside against the risks of project delays, policy changes, and competitive pressures in the biogas technology space.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.